Loading…
Adial Pharmaceuticals, Inc. is projected to decline to $2.62 by 2027, a -6% move from its current price of $2.78. ADIL is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $2.65 | $2.78 | $2.91 | -0.04% |
| Jul 13 | $2.60 | $2.78 | $2.97 | -0.08% |
| Jul 14 | $2.56 | $2.78 | $3.01 | -0.12% |
| Jul 15 | $2.53 | $2.78 | $3.05 | -0.16% |
| Jul 16 | $2.50 | $2.77 | $3.08 | -0.20% |
| Jul 17 | $2.47 | $2.77 | $3.11 | -0.23% |
| Jul 18 | $2.45 | $2.77 | $3.14 | -0.27% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.45 | $2.77 | $3.14 | -0.27% |
| Week 2 | $2.32 | $2.76 | $3.29 | -0.55% |
| Week 3 | $2.23 | $2.76 | $3.41 | -0.82% |
| Week 4 | $2.15 | $2.75 | $3.52 | -1.09% |
| Week 5 | $2.08 | $2.74 | $3.61 | -1.36% |
| Week 6 | $2.02 | $2.73 | $3.70 | -1.63% |
| Week 7 | $1.97 | $2.73 | $3.78 | -1.90% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Adial Pharmaceuticals, Inc. (ADIL) is a clinical-stage biopharmaceutical company in Healthcare that focuses on developing therapeutics for addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder.
The company was founded in 2010 and is based in Glen Allen, Virginia.
ADIL trades at $2.90 per share with a market capitalization of $6.35M and a rank of 5104. The stock has RSI14 of 60 and a neutral sentiment, with a 50-day simple moving average of $2.11 and a 200-day simple moving average of $4.78. The current price sits above the 50-day SMA and below the 200-day SMA, reflecting mixed near-term momentum.
The 30-day price range runs from $2.03 to $4.14, and annualized volatility is 100%. Near-term support is at $2.08 and resistance at $2.98.
A major floor 51.1% below — a decisive break under it would weaken the trend.
The nearest floor, 23.4% below — buyers have tended to step in here.
The nearest ceiling, 7.2% above — a clean break opens room to run.
A major ceiling 25.2% above — clearing it would confirm fresh momentum.
Key ADIL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ADIL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.85 | Sell | $2.81 | Sell |
| MA 10 | $2.77 | Buy | $2.78 | Buy |
| MA 20 | $2.73 | Buy | $2.67 | Buy |
| MA 50 | $2.24 | Buy | $2.45 | Buy |
| MA 100 | $2.07 | Buy | $2.86 | Sell |
| MA 200 | $4.64 | Sell | $5.21 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 57.53 | Neutral |
| Stoch RSI (14) | 44.35 | Neutral |
| CCI (20) | 20.76 | Neutral |
| Williams %R (14) | -30.23 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | 9.02 | Buy |
| Bollinger %B (20,2) | 0.57 | Neutral |
| Stochastic %K (14) | 69.77 | Neutral |
| TRIX (15) | 1.02 | Buy |
| Awesome (5,34) | 0.30 | Buy |
| Ultimate (7,14,28) | 66.51 | Neutral |
| Momentum (10) | 0.20 | Buy |
| Aroon Osc (25) | 12.00 | Buy |
| Hull MA (9) | 2.86 | Sell |
| ADX (14) | 21.41 | Buy |
| ATR (14) | 0.10 | Info |
In the near term, the 30-day range remains $2.03 to $4.14, with the current price at $2.90. RSI14 is 60, indicating neutral momentum, and the moving averages show SMA50 at $2.11 and SMA200 at $4.78. Support sits at $2.08 and resistance at $2.98.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.36 | $2.78 | $3.50 | 0% | Neutral | |
| $1.95 | $2.62 | $3.79 | -6% | Neutral | |
| $1.67 | $2.37 | $3.63 | -15% | Neutral | |
| $2.06 | $3.05 | $4.88 | +10% | Neutral | |
| $2.37 | $3.64 | $6.05 | +31% | Bullish | |
| $2.38 | $3.79 | $6.50 | +36% | Bullish | |
| $2.43 | $4.01 | $7.07 | +44% | Bullish | |
| $1.92 | $3.28 | $5.93 | +18% | Neutral | |
| $1.89 | $3.33 | $6.16 | +20% | Neutral | |
| $2.29 | $4.17 | $7.87 | +50% | Bullish | |
| $2.48 | $5.22 | $10.77 | +88% | Bullish | |
| $5.11 | $11.35 | $26.10 | +308% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.36 | $2.78 | $3.37 | +0.00% |
| August 2026 | $2.34 | $2.82 | $3.53 | +1.51% |
| September 2026 | $2.20 | $2.68 | $3.41 | -4.94% |
| October 2026 | $2.04 | $2.51 | $3.24 | -6.38% |
| November 2026 | $2.08 | $2.58 | $3.37 | +2.65% |
| December 2026 | $2.11 | $2.65 | $3.50 | +2.61% |
Click any year to see its month-by-month ADIL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ADIL price prediction for 2026 points to an average of $2.78 (low $1.36, high $3.50) — a potential gain of 0% on today's $2.78. A consolidation phase looks the most probable path here.
In 2027, ADIL is projected to trade between $1.95 and $3.79, averaging $2.62 — a potential decline of -6% from today's $2.78. That is -6% versus the projected 2026 average. Price action looks broadly range-bound.
Adial Pharmaceuticals, Inc.'s 2028 outlook centres on $2.37, within a $1.67 to $3.63 range. That is -10% versus the projected 2027 average. That marks a -15% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, ADIL could reach as high as $4.88, with a base case around $3.05 and support toward $2.06 — roughly +10% from $2.78. Price action looks broadly range-bound.
Expect ADIL to range from $2.37 to $6.05 through 2030. The $3.64 average target implies a +31% move from current prices. That is up +19% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The ADIL price prediction for 2031 points to an average of $3.79 (low $2.38, high $6.50) — a potential gain of +36% on today's $2.78. Momentum favours further upside here.
In 2032, ADIL is projected to trade between $2.43 and $7.07, averaging $4.01 — a potential gain of +44% from today's $2.78. That is up +6% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Adial Pharmaceuticals, Inc.'s 2033 outlook centres on $3.28, within a $1.92 to $5.93 range. That is -18% versus the projected 2032 average. That marks a +18% change versus current levels. Price action looks broadly range-bound.
By 2034, ADIL could reach as high as $6.16, with a base case around $3.33 and support toward $1.89 — roughly +20% from $2.78. A consolidation phase looks the most probable path here.
Expect ADIL to range from $2.29 to $7.87 through 2035. The $4.17 average target implies a +50% move from current prices. That is up +25% on the projected 2034 average. Momentum favours further upside here.
The ADIL price prediction for 2040 points to an average of $5.22 (low $2.48, high $10.77) — a potential gain of +88% on today's $2.78. Buyers look set to stay in control over this stretch.
In 2050, ADIL is projected to trade between $5.11 and $26.10, averaging $11.35 — a potential gain of +308% from today's $2.78. That is up +117% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ADIL today (≈ 359.71223 ADIL) could be worth
$4,081.97
+$3,081.97 (+308%) by 2050 · US Dollar
Based on the average projected ADIL price of $11.35 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ADILwould be worth at today's price.
$1,000 invested in ADIL on Jul 10, 2025 (≈ 97.560976 ADIL) would be worth
$271.22
-$728.78 (-72.9%) today · 0.27× · US Dollar
Based on a ADIL entry price of $10.25 vs. today's $2.78.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.9 | $958.62 | -4.1% |
| 1 month ago | $2.16 | $1,287.04 | +28.7% |
| 3 months ago | $1.57 | $1,770.7 | +77.1% |
| 6 months ago | $5.75 | $483.48 | -51.7% |
| 1 year ago | $10.25 | $271.22 | -72.9% |
| All time (5.0y) ago | $1,712.5 | $1.62 | -99.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ADIL forecast.
Our base-case forecast reaches $5.60 around 2050.
Implied market cap at $5.60: $12.26M
The multi-year forecast shows a path of gradual upside with notable milestones. The 2026 average is $2.90 (min $1.36, max $3.67) and the ROI is 0. The 2027 forecast is $2.68 (min $1.94, max $4.01) with ROI -7.5.
The 2028 forecast is $2.46 (min $1.68, max $3.92) with ROI -15.1. The 2029 forecast is $3.26 (min $2.11, max $5.44) with ROI 12.5. The 2030 forecast is $4.00 (min $2.47, max $6.95) with ROI 38 and is labeled BULLISH, followed by 2031 at $4.18 (min $2.47, max $7.51) ROI 44.1 and BULLISH, and 2032 at $4.29 (min $2.43, max $7.96) ROI 48 and BULLISH.
In 2033 the forecast is $3.42 (min $1.86, max $6.51) ROI 17.8 NEUTRAL, 2034 is $3.57 (min $1.87, max $6.98) ROI 23.2 BULLISH, 2035 is $4.56 (min $2.30, max $9.12) ROI 57.3 BULLISH. The long-horizon view shows 2040 at $5.71 (min $2.57, max $12.55) ROI 97 BULLISH and 2050 at $12.78 (min $5.75, max $29.40) ROI 340.7 BULLISH. These are estimates and not guarantees, with the overall path indicating substantial upside potential in later years amid inherent uncertainties and market volatility.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $4.00 with a min of $2.47 and a max of $6.95, and a forecast ROI of 38. The sentiment for 2030 is BULLISH.
The forecast includes years with bullish sentiment (2030, 2031, 2032, 2034, 2035, 2040, 2050) and positive average prices such as $4.00 in 2030 and $12.78 in 2050, with ROIs of 38, 44.1, 48, 23.2, 57.3, 97, and 340.7 respectively. However, there are earlier years with neutral or bear signals (e.g., 2027 ROI -7.5%, 2028 ROI -15.1%). These are estimates, not guarantees.
Yes. The 2040 forecast shows an average price of $5.71 with a max of $12.55, implying the asset could exceed $5 by 2040.
Current price is $2.90 and the market cap is $6.35M.
The 30-day range is $2.03 to $4.14; RSI14 is 60; the SMA50 is $2.11 and the SMA200 is $4.78. There is support at $2.08 and resistance at $2.98, with a neutral overall technical stance.
Adial Pharmaceuticals, Inc. Community Discussion
0Share your Adial Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.